Details of the Drug
General Information of Drug (ID: DM3PZLM)
| Drug Name |
NGR-hTNF
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Arenegyr; NGR-hTNF (solid tumors); Tumor necrosis factor therapy (recombinant protein), MolMed; CD13 TNF-alpha conjugate (solid tumors), MolMed; NGR-hTNF (solid tumors), MolMed; Vascular-targeted TNF (NGR-TNF), MolMed SpA; Vascular-targeted TNF (solid tumors, iv/infusion/biological therapeutic), MolMed
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
| Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||
References
